[1]李 敏,刘福明,邢俊武,等.葶苈大枣泻肺汤合决渎汤治疗心力衰竭阳虚水泛证临床研究[J].陕西中医,2023,(6):721-725.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.008]
　LI Min,LIU Fuming,XING Junwu,et al.Analysis of curative effect of Tingli Dazao Xiefei decoction and Juedu decoction in heart failure with yang deficiency and water flooding syndrome[J].,2023,(6):721-725.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.008]
点击复制

葶苈大枣泻肺汤合决渎汤治疗心力衰竭阳虚水泛证临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年6期
页码:
721-725
栏目:
临床研究
出版日期:
2023-06-05

文章信息/Info

Title:
Analysis of curative effect of Tingli Dazao Xiefei decoction and Juedu decoction in heart failure with yang deficiency and water flooding syndrome
作者:
李 敏1; 刘福明2; 邢俊武1; 朱云仙1; 伯广干1; 苏晓叶1; 吴定坤1
(1.南京市中西医结合医院心内科,江苏 南京 210018; 2.江苏省中医院心内科,江苏 南京 210029)
Author(s):
LI Min; LIU Fuming; XING Junwu; ZHU Yunxian; BO Guanggan; SU Xiaoye; WU Dingkun
(Department of Cardiology,Nanjing Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing 210018,China)
关键词:
心力衰竭;  阳虚水泛证;  葶苈大枣泻肺汤;  决渎汤;  心功能;  血管紧张素Ⅱ;  同型半胱氨酸
Keywords:
Heart failure;  Syndrome of yang deficiency and water flooding;  Tingli Dazao Xiefei decoction;  Juedu decoction;  Cardiac function;  Angiotensin Ⅱ;  Homocysteine
分类号:
R 541.61
DOI:
DOI:10.3969/j.issn.1000-7369.2023.06.008
文献标志码:
A
摘要:
目的:探究葶苈大枣泻肺汤合决渎汤在心力衰竭阳虚水泛证中的临床疗效。方法:将86例慢性心力衰竭患按照随机数字表法分为观察组和对照组,各43例,对照组采用左西孟坦治疗,观察组予葶苈大枣泻肺汤合决渎汤治疗。治疗2周后,比较两组的中医症候评分、左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、左心室射血分数(LVEF)、N-脑钠肽前体(NT-proBNP)、高敏心肌肌钙蛋白(hsTn)T、血管紧张素Ⅱ(AgnⅡ)、同型半胱氨酸(Hcy)、疗效及不良反应。结果:治疗后,两组主症积分、次症积分均降低,观察组低于对照组(P<0.05); 两组LVEF均升高,观察组高于对照组(P<0.05); 两组LVESD及LVEDD均降低,观察组低于对照组(P<0.05); 两组NT-proBNP、hsTnT、AgnⅡ、Hcy均降低,观察组低于对照组(P<0.05)。观察组临床疗效优于对照组(P<0.05)。两组治疗期间均未出现严重不良反应。结论:葶苈大枣泻肺汤合决渎汤治疗阳虚水泛证心力衰竭,有助于促进患者心功能的恢复,临床疗效优越且安全性较好。
Abstract:
Objective:To explore the therapeutic effect of Tingli Dazao Xiefei decoction and Juedu decoction in the treatment of heart failure with yang deficiency and water flooding syndrome.Methods:86 patients with chronic heart failure were divided into observation group and control group according to random number table method,43 patients in each group.The control group was treated with levosimontan,and the observation group was treated with combination of Tingli Dazao Xiefei decoction and Juedu decoction.After 2 weeks of treatment,the TCM syndrome score,left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD),left ventricular ejection fraction(LVEF),N-proBNP precursor(NT-proBNP),high-sensitivity cardiac troponin(hsTn)T,angiotensin Ⅱ(AgnⅡ),homocysteine(Hcy),efficacy and adverse reactions were compared between the two groups.Results:After treatment,the main syndrome score and secondary syndrome score of the two groups decreased,and the observation group was lower than the control group(P<0.05); LVEF in both groups was higher than that in the control group(P<0.05); LVESD and LVEDD in the two groups were lower than those in the control group(P<0.05); NT-proBNP,hsTnT,AgnⅡ and Hcy in the two groups were lower than those in the control group(P<0.05).The clinical effect of the observation group was better than that of the control group(P<0.05).There were no serious adverse reactions during treatment in both groups.Conclusion:Tingli Dazao Xiefei decoction combined with Juedu decoction in the treatment of heart failure due to yang deficiency and water flooding syndrome was helpful to promote the recovery of patients' cardiac function,with superior clinical efficacy and good safety.

参考文献/References:

[1] Pagliaro BR,Cannata F,Stefanini GG,et al.Myocardial ischemia and coronary disease in heart failure[J].Heart Fail Rev,2020,25(1):53-65.
[2] 董其浩,邓 兵.益脉强心汤对冠心病合并心力衰竭患者心室重构及血清血小板活化因子、转化生长因子-β1的影响[J].陕西中医,2021,42(7):883-885,913.
[3] 刘云璐,王承龙,王 强,等.戊巴比妥钠诱导心力衰竭心肌细胞损伤模型的构建及鉴定[J].陕西医学杂志,2022,51(1):3-6.
[4] Korpela H,Jarvelainen N,Siimes S,et al.Gene therapy for ischaemic heart disease and heart failure[J].J Intern Med,2021,290(3):567-582.
[5] 郭 鸿,孙 茹.决渎汤合真武汤治疗阳虚水泛型慢性心肾综合征的疗效观察[J].中西医结合心脑血管病杂志,2021,19(24):4323-4326.
[6] 耿 艳,胡柏生,姜 颢.真武汤合葶苈大枣泻肺汤辅助治疗慢性心力衰竭急性失代偿期疗效观察[J].中国中医急症,2022,31(7):1228-1231.
[7] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.
[8] 国家食品药品监督管理总局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:304-309.
[9] 陈 莹,郑 辉,何 玉.合并冠心病的老年射血分数保留心力衰竭患者营养状态与预后的关系研究[J].中国全科医学,2023,26(3):335-342.
[10] 羡微微,刘桂清.沙库巴曲缬沙坦对射血分数降低性心力衰竭患者血浆去甲肾上腺素和血清心肌肌钙蛋白I水平的影响研究[J].陕西医学杂志,2020,49(10):1306-1309.
[11] Nichols S,Mcgregor G,Breckon J,et al.Current insights into exercise-based cardiac rehabilitation in patients with coronary heart disease and chronic heart failure[J].Int J Sports Med,2021,42(1):19-26.
[12] Saldarriaga C,Atar D,Stebbins A,et al.Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction[J].Eur J Heart Fail,2022,24(5):782-790.
[13] 张和针,梁宇鹏,刘培中,等.真武汤合葶苈大枣泻肺汤治疗急性心力衰竭患者的临床观察[J].中国中医急症,2021,30(10):1793-1796.
[14] 郭 允,王学工.加味益气强心汤对心阳亏虚型慢性心力衰竭患者心功能、血管内皮功能的影响[J].陕西中医,2021,42(4):456-458.
[15] 乔利杰,朱明军,李 彬,等.基于网络药理学研究葶苈大枣泻肺汤治疗心力衰竭的作用机制[J].辽宁中医杂志,2021,48(7):147-152.
[16] 李永刚,刘丽杰,曹玉军,等.小青龙汤合葶苈大枣泻肺汤治疗慢性心力衰竭寒痰阻肺证临床研究[J].国际中医中药杂志,2020,42(4):324-328.
[17] 李 倩,申凤霞,马 云,等.基于网络药理学和分子对接技术探讨葶苈大枣泻肺汤治疗慢性肺心病的作用机制[J].现代中药研究与实践,2021,35(6):33-39.
[18] 赵 洁,王欢欢,欧阳意,等.基于网络药理学及质谱技术的葶苈大枣泻肺汤抗心力衰竭的有效成分发现及作用机制分析[J].中国实验方剂学杂志,2021,27(8):151-160.
[19] 程吉成,曾传生,方紫艺.加味葶苈大枣泻肺汤治疗心力衰竭疗效观察[J].四川中医,2020,38(6):96-98.
[20] 李玉明,訾素娜,汪晓艳,等.加味葶苈大枣泻肺汤对慢性心力衰竭临床疗效的研究[J].世界科学技术-中医药现代化,2019,21(7):1542-1547.
[21] 吴紫阳,孙 静,杨 君.真武汤合葶苈大枣泻肺汤加减治疗慢性心力衰竭阳虚水泛证的临床研究[J].中西医结合心脑血管病杂志,2021,19(16):2712-2716.
[22] 卢卫娅,张云青,王仲君,等.蠲饮宁心煎治疗慢性左心力衰竭的临床疗效及对血清NT-proBNP、GDF-15和超声心功能指标的影响[J].河北中医药学报,2021,36(1):15-18.
[23] 张 洁,高 伟,刘淑敏,等.补阳还五汤合葶苈大枣泻肺汤加减结合西医常规疗法治疗慢性心力衰竭气虚血瘀饮停证临床研究[J].国际中医中药杂志,2021,43(7):638-642.
[24] 林雪竹,李蔚群,关永霞,等.葶苈子化学成分及药理作用研究进展[J].中国现代中药,2022,24(3):550-558.
[25] 范晓艳,王元耕,陈泽涛.黄芪桂枝五物汤治疗心力衰竭的网络药理学机制[J].山东大学学报:医学版,2022,60(11):70-81.
[26] 刘 梅,郭小红,孙 全,等.温郁金的化学成分和药理作用研究进展[J].现代药物与临床,2021,36(1):204-208.
[27] 祝晓丽,高家荣,施苗苗,等.黄芪-白茅根治疗慢性肾小球肾炎作用机制的可视化分析[J].山东科学,2022,35(4):58-67.
[28] 王倩倩,陈 豪,辛泰然,等.基于数据挖掘的葶苈大枣泻肺汤“泻肺”内涵及临床配伍规律探析[J].世界科学技术-中医药现代化,2021,23(7):2434-2439.
[29] 王艳敏.葶苈大枣泻肺汤加减联合西医常规治疗心力衰竭临床研究[J].新中医,2021,53(14):25-28.

相似文献/References:

[1]杨禹娟,张勇,吕军,等.益气复脉注射液治疗老年冠心病并发慢性心力衰竭30例[J].陕西中医,2016,(10):1325.
　Yang Yujuan,Zhang Yong,Lv Jun,et al.[J].,2016,(6):1325.
[2]任红杰,赵安社,安谊沛,等.芪苈强心胶囊联合西药治疗慢性心力衰竭疗效及对患者NT-proBNP、hs-CRP、VEGF的影响*[J].陕西中医,2019,(6):711.
[3]隋艳波,凌丽云,刘 莉.“血不利则为水”理论论治心力衰竭研究[J].陕西中医,2021,(2):213.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.019]
　SUI Yanbo,LING Liyun,LIU Li.Treating heart failure based on the theory of “Unsmooth blood circulation results in water”[J].,2021,(6):213.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.019]
[4]刘晨萍,董耀荣,袁晨越.温阳利水法治疗中晚期慢性心力衰竭研究进展[J].陕西中医,2021,(6):811.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.034]
[5]陈仁山,肖惠珍,刘 宁,等.参芪扶正注射液抑制ERK1/2、GATA4信号通路改善小鼠心力衰竭实验研究[J].陕西中医,2022,(1):8.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.002]
　CHEN Renshan,XIAO Huizhen,LIU Ning,et al.Effect of Shenqi Fuzheng injection on heart failure in mice by inhibiting ERK1/2,GATA4 signaling pathway[J].,2022,(6):8.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.002]
[6]尼苦王康,邓 兵.中药治疗射血分数保留的心力衰竭研究进展[J].陕西中医,2022,(3):405.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.033]
　NiKU Wangkang,DENG Bing.Research progress of traditional Chinese medicine in treating heart failure with preserved ejection fraction[J].,2022,(6):405.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.033]
[7]寇林利,赵明君,魏明明,等.苓桂术甘汤对慢性心力衰竭大鼠心肌功能及心室重构的影响[J].陕西中医,2022,(9):1170.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.004]
　KOU Linli,ZHAO Mingjun,WEI Mingming,et al.Effect on improvement of myocardial function and ventricular remodeling in rats with chronic heart failure by Linggui Zhugan decoction[J].,2022,(6):1170.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.004]
[8]周 媛,李启注,徐京育.苓桂术甘汤治疗心力衰竭研究进展[J].陕西中医,2022,(12):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]
　ZHOU Yuan,LI Qizhu,XU Jingyu.Overview of the clinical application of Linggui Zhugan prescription in the treatment of heart failure[J].,2022,(6):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]
[9]陈铭钦,雷瑗琳,师瑞瑞,等.益心附葶饮对慢性心力衰竭心肾阳虚证大鼠HIF-1/VEGF信号通路的影响[J].陕西中医,2023,(11):1527.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.007]
　CHEN Mingqin,LEI Yuanlin,SHI Ruirui,et al.Effect of Yixin Futing Yin on HIF-1/VEGF signaling pathway in rats with chronic heart failure of Xinshen Yangxu syndrome[J].,2023,(6):1527.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.007]
[10]曹晓璇,胡佳裕,张钰欣,等.基于“三焦气化”论治老年心力衰竭利尿剂抵抗[J].陕西中医,2023,(11):1585.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.021]

备注/Memo

备注/Memo:
基金项目:江苏省中医药科技发展计划重点项目(ZD201906)
更新日期/Last Update: 2023-06-09